WealthShield Partners’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-500
Closed -$106K 560
2021
Q2
$106K Hold
500
0.02% 355
2021
Q1
$91K Buy
+500
New +$99.6K 0.02% 352

Other funds holding NVAX

WealthShield Partners's NVAX Position: Q3 2021 in Review

WealthShield Partners sold out of Novavax (NVAX) in Q3 2021, closing a stake of 500 shares — an estimated $106K sold.

WealthShield Partners first reported a position in NVAX in Q1 2021 and held it in 2 quarters. The position peaked at $106K in Q2 2021. 442 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • WealthShield Partners reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
  • WealthShield Partners sold 500 Novavax shares in Q3 2021, an estimated $106K.
  • WealthShield Partners first reported a position in Novavax in Q1 2021 and held it in 2 quarters.
  • WealthShield Partners's Novavax position peaked at $106K in Q2 2021.
  • 442 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on WealthShield Partners's 13F filing for Q3 2021, filed 12 Nov 2021.